Nandrolone Decanoate (Deca-Durabolin)
nan-DROL-one
Category
Compound type
Phase / Status
An androgenic compound with medical and veterinary history; risks and appropriate use depend on indication and clinician guidance. Banned by WADA for sport participation.
Standard Dose
Once or twice weekly
Half-life
Plasma elimination
Route(s)
Oral
Research Stage
Regulatory approval granted; post-market monitoring ongoing.
Overview
Nandrolone decanoate is an androgen therapy that can affect muscle and bone metabolism. It can also suppress natural hormone production and may cause side effects related to cardiovascular health, liver function, and reproductive/sexual function depending on dose and individual factors.
Plain-language summary
Nandrolone decanoate is an androgen therapy that can affect muscle and bone metabolism. It can also suppress natural hormone production and may cause side effects related to cardiovascular health, liver function, and reproductive/sexual function depending on dose and individual factors.
Administration Routes
- Oral
Also known as
Mechanisms
A 19-nortestosterone derivative with a decanoate ester (injectable). It binds to androgen receptors and influences protein synthesis and other androgen-dependent pathways. The decanoate ester formulation is designed for slower release.
Detailed mechanism
19-nortestosterone derivative (injectable anabolic steroid with decanoate ester). It binds to androgen receptors and influences downstream signaling involved in protein synthesis, nitrogen retention, and collagen-related pathways.
Safety
Side effects
- Suppression of natural testosterone production
- Potential estrogen/androgen-related side effects (e.g., gynecomastia risk depends on individual metabolism)
- Potential effects on lipids and cardiovascular risk profile
- Acne/hair-related effects in susceptible individuals
- Injection site pain or other injection-related issues
Reported benefits
- Potential changes in muscle and strength under certain conditions
- Possible effects related to joint comfort for some people (indirect mechanisms possible)
- Established pharmacology in medical and veterinary contexts
Safety profile
Androgenic therapies have well-described risks. Safety depends on indication, dose, duration, baseline health, and monitoring.
Clinical trials
Completed clinical research leading to regulatory approval in some indications.
Structure
Verified structure
Nandrolone Decanoate (Deca-Durabolin)
No exact public structure match was confirmed, so the app will render a formula-backed illustration.
- Chemical Formula
- C29H44O3
- Molecular Weight
- 452.67 g/mol
- CAS Number
- 360-70-3
Stack Context
Stacks with
References
- 1View source
Anabolic effects of nandrolone decanoate in patients receiving dialysis: a randomized controlled trial (JAMA)
1999
- 2View source
Effects of androgenic-anabolic steroids in athletes (Sports Medicine)
2004
- 3View source
Pharmacology of anabolic steroids (British Journal of Sports Medicine)
2008
This profile summarizes research literature for education only. It is not medical advice, and it does not diagnose, treat, or recommend a dose. Consult a qualified professional before changing a protocol.